Lars Åke Martin
Chairman at Chromafora AB
Network origin in Lars Åke Martin first degree
Entity | Entity type | Industry | |
---|---|---|---|
Chromafora AB
Chromafora AB Environmental ServicesIndustrial Services Chromafora AB offers water purification and technology for selective heavy metal separation to a global market. It provides chemical reducing technology. Its services include selective metal extraction to handle waste streams containing dissolved heavy metals and chemical synthesis. The company was founded by Martin Kullberg, Karl Gaston Lavén, and Henrik Joachim Rundgren in 2010 and is headquartered in Solna, Sweden.
6
| Holding Company | Environmental Services | 6 |
CareDx International (Private Equity)
CareDx International (Private Equity) Investment ManagersFinance Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies.
4
| Operating Division | Investment Managers | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lars Åke Martin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Provell Pharmaceuticals LLC
Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member | |
ALLENEX AB | Biotechnology | Chief Executive Officer Founder Corporate Officer/Principal Corporate Officer/Principal | |
Recipharm Monts SAS
Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019. | Pharmaceuticals: Major | Chairman | |
SymCel AB
SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member | |
Olerup International AB
Olerup International AB BiotechnologyHealth Technology Olerup International AB distributes molecular diagnostic products and services for human leukocyte antigen (HLA) typing and antibody detection. It offers transplant diagnostics and supportive software. The firm provides products and services for bone marrow and organ transplantation. Its HLA portfolio consists of two product lines, Sequence Specific Primer Genomic HLA Typing and Sequencing Based Typing. The company was founded in 2009 and is headquartered in Stockholm, Sweden. | Biotechnology | Chief Executive Officer Chairman | |
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
IMED AB
IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Director/Board Member | |
Kabivitrum AB | Corporate Officer/Principal | ||
Vitrum Holding AG
Vitrum Holding AG Containers/PackagingProcess Industries Part of Bayerische Flaschen-Glashüttenwerke Wiegand & Söhne GmbH & Co., Vitrum Holding AG operates as a holding Swiss company with interests in glass container manufacturing. The company is based in Hüneberg, Switzerland. Vitrum Holding was acquired by Wiegand - Glas Holding GmbH on December 16, 2011. | Containers/Packaging | Corporate Officer/Principal | |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Almi Invest AB
Almi Invest AB Investment ManagersFinance Almi Invest AB (Almi) is a Venture Capital subsidiary of ALMI Företagspartner AB, founded in 2009. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Quantovir AB
Quantovir AB Miscellaneous Commercial ServicesCommercial Services Quantovir AB conducts research and development of methods for cancer diagnostics and related business. It develops technology for quantitative measurement of high-risk Human Papillomavirus (HPV) types using deoxyribonucleic acid (DNA)-based detection. It demonstrates that a molecular diagnostic test measuring the quantity, or viral load, of HPV DNA present in cervical specimens can be used to predict a woman's risk of developing cervical cancer. The company was founded by Ulf Gyllensten on February 28, 2001 and is headquartered in Uppsala, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
SVENSKA AEROGEL HOLDING AB | Chemicals: Specialty | Director/Board Member | |
Fisons Pharmaceuticals | President | ||
Zentricity International AB
Zentricity International AB Financial ConglomeratesFinance Zentricity International AB provides investment services. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Aesica Holdco Ltd.
Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK. | Pharmaceuticals: Major | Director/Board Member | |
XINTELA AB | Biotechnology | Director/Board Member | |
B&E Invest AB | Director/Board Member | ||
TOLERANZIA AB | Biotechnology | Director/Board Member | |
Psilox AB
Psilox AB Medical SpecialtiesHealth Technology Psilox AB engages in the manufacture and application of bio ceramic materials. It offers calcium phosphate microspheres used in treatments in dentistry and medicine. The company was founded by Håkan Gunnar Engqvist and Wei Xia on May 29, 2013 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
Recipharm Fontaine SAS
Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman | |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Chairman | |
ExScale Biospecimen Solutions AB
ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Biotechnology | Director/Board Member | |
Gradientech AB
Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Biotechnology | Director/Board Member | |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
Bohus HoldCo AB
Bohus HoldCo AB Chemicals: Major DiversifiedProcess Industries Bohus BioTech AB is a Swedish company that manufactures and develops hyaluronic acid products. The company is based in Stromstad, Sweden and has subsidiaries in Sweden. The company was founded in 1992 by Daniel C. Ogbonnaya. | Chemicals: Major Diversified | Director/Board Member | |
B&E Participation, Inc. | Chairman | ||
Zentricity Holding AB
Zentricity Holding AB Financial ConglomeratesFinance Zentricity Holding AB provides investment services. It offers venture capital to startup companies. The company is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
VBN Components AB
VBN Components AB Building ProductsProducer Manufacturing VBN Components AB provides 3D-printed components for industrial producers. It also offers additive manufacturing, wear resistant materials, complex component shapes, and powder metallurgy and tribology services. The company was founded by Ulrik Beste and Leif Martin Nilsson in 2008 and is headquartered in Uppsala, Sweden. | Building Products | Director/Board Member | |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Flerie Participation AB
Flerie Participation AB Financial ConglomeratesFinance Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Scania Credit AB | Chief Executive Officer | ||
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chairman | |
Recipharm Verwaltungs GmbH
Recipharm Verwaltungs GmbH Financial ConglomeratesFinance Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman | |
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. | Miscellaneous | Director/Board Member | |
Consort Medical GmbH
Consort Medical GmbH Financial ConglomeratesFinance Part of Recipharm AB, Consort Medical GmbH is a German company that functions as an investment holding company. The company is based in Monheim, Germany. The CEO of the company is Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member | |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Chairman | |
NANOLOGICA AB | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
Sweden | 35 |
United Kingdom | 8 |
United States | 4 |
France | 3 |
Germany | 3 |
Sectoral
Health Technology | 25 |
Finance | 8 |
Commercial Services | 5 |
Process Industries | 4 |
Producer Manufacturing | 3 |
Operational
Director/Board Member | 44 |
Chief Executive Officer | 17 |
Chairman | 16 |
Corporate Officer/Principal | 12 |
President | 11 |
Most connected contacts
- Stock Market
- Insiders
- Lars Åke Martin
- Company connections